LSW EVS WIN grad and former Athira Pharma CEO Leen Kawas has returned to the Seattle-area biotech scene as CEO of Kirkland-based EIT Pharma. The company is developing treatments for chronic hepatitis D, with its lead drug, lonafarnib, having completed Phase 3 trials and recently receiving FDA acceptance for review.
LSW EVS WIN Grad & Former Athira CEO, Leen Kawas, Returns to Seattle Biotech Scene with Kirkland Company
Share: